Celyad Announces February and March 2020 Conference Schedule

Regulatory News: Celyad (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that the company plans to participate at the following conferences in February and March 2020: 9th Annual SVB Leerink Global Healthcare Conference